SUCCESS STORY: ASTRAZENECA AstraZeneca A remedy for IVR growing pains How does big pharma deal with the exacting demands of a highly regulated industry? Ask John DiBrango, Channel Management and Governance Director for AstraZeneca Pharmaceuticals. His challenge: streamline the company’s IVR systems and present a consistent, company-centric voice to the customer. Pharmaceutical companies are subject to intense government regulation, resulting in a high volume of frequent changes to marketing programs. For AstraZeneca, add to this a complex tangle of interactive voice response (IVR) systems, grown over time and managed by multiple vendors across multiple brands. Turnaround for even a minor change could be as long as eight weeks. In this highly regulated industry where complianc

Join for free to read